109 related articles for article (PubMed ID: 15704494)
1. Expression of biologically active kringle 5 domain of human plasminogen in Escherichia coli.
Zhang HX; Fang L; Cheng J; Wei Z; Hua ZC
Prep Biochem Biotechnol; 2005; 35(1):17-27. PubMed ID: 15704494
[TBL] [Abstract][Full Text] [Related]
2. Expression of kringle 5 domain of human plasminogen in Pichia pastoris.
Zhu M; Cheng J; Hua ZC
Prep Biochem Biotechnol; 2003 Nov; 33(4):269-81. PubMed ID: 14606685
[TBL] [Abstract][Full Text] [Related]
3. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris.
Zhou Y; Zheng Q; Gao J; Gu J
Biotechnol Lett; 2005 Feb; 27(3):167-71. PubMed ID: 15717125
[TBL] [Abstract][Full Text] [Related]
4. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
5. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
6. Expression of recombinant kringle 1-5 domains of human plasminogen by a prokaryote expression system.
Hou WH; Fang T; Chai YR; Wang TY; Wang JM; Xue LX
Protein Expr Purif; 2006 May; 47(1):93-8. PubMed ID: 16510293
[TBL] [Abstract][Full Text] [Related]
7. Expression, purification of human vasostatin120-180 in Escherichia coli, and its anti-angiogenic characterization.
Sun QM; Cao L; Fang L; Chen C; Dai J; Chen LL; Hua ZC
Protein Expr Purif; 2005 Feb; 39(2):288-95. PubMed ID: 15642481
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
9. An improved strategy for high-level production of human vasostatin120-180.
Sun QM; Chen LL; Cao L; Fang L; Chen C; Hua ZC
Biotechnol Prog; 2005; 21(4):1048-52. PubMed ID: 16080682
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of recombinant human micro-plasminogen.
Ma Z; Lu W; Wu S; Chen J; Sun Z; Liu JN
Biotechnol Lett; 2007 Apr; 29(4):517-23. PubMed ID: 17206368
[TBL] [Abstract][Full Text] [Related]
12. [Two incompatible plasmids coexpress the human endostatin and predigested human plasminogen kringle 5 in E. coli].
Sun J; Wang JQ; Zhai ZY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):839-43. PubMed ID: 17236576
[TBL] [Abstract][Full Text] [Related]
13. [A deletion mutant of plasminogen kringle 5 inhibits retinal capillary endothelial cell proliferation].
Ma JF; Yang ZH; Li CY; Cai WB; Song ZH; Guo Y; Guo LL; Li MY; Liu ZG; Gao GQ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1245-8. PubMed ID: 14678880
[TBL] [Abstract][Full Text] [Related]
14. Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5.
Dudley A; McKinstry W; Thomas D; Best J; Jenkins A
Biotechniques; 2003 Oct; 35(4):724-6, 728, 730 passim. PubMed ID: 14579737
[TBL] [Abstract][Full Text] [Related]
15. Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Medynski D; Tuan M; Liu W; Wu S; Lin X
Protein Expr Purif; 2007 Apr; 52(2):395-402. PubMed ID: 17126563
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization.
Cai W; Ma J; Li C; Yang Z; Yang X; Liu W; Liu Z; Li M; Gao G
J Cell Biochem; 2005 Dec; 96(6):1254-61. PubMed ID: 16167344
[TBL] [Abstract][Full Text] [Related]
17. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
18. [Effects of human plasminogen Kringle 5 gene therapy on pancreatic cancer].
Shi CQ; Li ZD; Zhang QH; Ni QX; Jin C; Zhang N; Song N
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1827-32. PubMed ID: 15631784
[TBL] [Abstract][Full Text] [Related]
19. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and functional study of an adenovirus vector expressing human plasminogen kringle 5 gene].
Yang J; Wang YX; Guan XQ; Ma CG; Wang LS; Song HY
Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):217-22. PubMed ID: 15966325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
